FDA recall record

Vita Warehouse 1 recall — FDA H-0212-2025

Contains undeclared peanut

Class Iclassification
H-0212-2025official record ID
Jul 9, 2025report date

Recall record at a glance

Official recordH-0212-2025
CategoryFood Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmVita Warehouse Corp.
Report dateJul 9, 2025
Recall initiation dateJun 11, 2025
Quantity40,522 bottles plus 582,000 individual gummies
LocationRonkonkoma, NY, United States

Official product description

1. Welby Vitamin B12 Adult Gummies 140 Count 2. Berkely Jensen Vitamin B12 1000 mcg Gummies 250 count 3. VitaGlobe" Vitamin B12 Extra Strength Gummies 140 count 3. Vita Labs Vitamin B-12 Gummies Bulk 500 count

Why the product was recalled

Contains undeclared peanut

Distribution information

Nationwide

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.